IBRX: Simon Barry J. discloses a sale

By AlphaYouPublished Oct 6, 2026Form 4

Stocks in this disclosure

Reported activity

Simon Barry J.

Reporting filer

Simon Barry J. reported Sale in ImmunityBio, Inc.: 25000 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 6, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Simon Barry J.	2026-10-05	S	Sale	25000	10.7504	2,777,788	1 day	Filed terms security Title: Common Stock transaction Date: 2026-10-05 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 25000 transaction Price Per Share: 10.7504 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 2777788 direct Or Indirect Ownership: D

Common Stock

Owner: Simon Barry J.
Date: 2026-10-05
Code: S
Action: Sale
Quantity: 25000
Price: 10.7504
Following holdings: 2,777,788
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-05
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 25000
transaction Price Per Share: 10.7504
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 2777788
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Simon Barry J.: Director.
The filing reports a Rule 10b5-1 trading plan.
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2025.
F2: Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $10.665 to $10.78 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Simon Barry J.

2026-10-05

Sale

25000

10.7504

2,777,788

1 day

Filed terms

security Title: Common Stock
transaction Date: 2026-10-05
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 25000
transaction Price Per Share: 10.7504
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 2777788
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Simon Barry J.: Director.

The filing reports a Rule 10b5-1 trading plan.

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2025.

F2: Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $10.665 to $10.78 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.